title: Normal prothrombin times in the presence of therapeutic levels of apixaban--in-vivo experience from King's College Hospital.
authors.affiliation: King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital Foundation NHS Trust, London, UK; Institute of Pharmaceutical Science, King's College London, London, UK. jig.patel@kcl.ac.uk.
authors.forename: Jignesh P
authors.initials: JP
authors.lastname: Patel
authors.forename: Paradzai B
authors.initials: PB
authors.lastname: Chitongo
authors.forename: Julia
authors.initials: J
authors.lastname: Czuprynska
authors.forename: Lara N
authors.initials: LN
authors.lastname: Roberts
authors.forename: Raj K
authors.initials: RK
authors.lastname: Patel
authors.forename: Roopen
authors.initials: R
authors.lastname: Arya
mesh_terms: D065427:Factor Xa Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006785:Hospitals, University; D006801:Humans; D008297:Male; D011517:Prothrombin Time / Q000379:methods*; D011720:Pyrazoles / Q000008:administration & dosage / Q000493:pharmacokinetics; D011728:Pyridones / Q000008:administration & dosage / Q000493:pharmacokinetics
chemical_list: D065427:Factor Xa Inhibitors; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban
keywords: apixaban; direct-Xa inhibitors; prothrombin time